Newborn Screening for Spinal Muscular Atrophy (SMA) - a Proof of Principle Study Using Anonymised Blood Spots.
CompletedOBSERVATIONAL
Enrollment
5,065
Participants
Timeline
Start Date
November 11, 2019
Primary Completion Date
March 30, 2021
Study Completion Date
March 30, 2021
Conditions
Spinal Muscular Atrophy
Trial Locations (1)
WC1N 1EH
Dubowitz Neuromuscular Centre, London
All Listed Sponsors
lead
Great Ormond Street Hospital for Children NHS Foundation Trust
OTHER
NCT05237544 - Newborn Screening for Spinal Muscular Atrophy (SMA) - a Proof of Principle Study Using Anonymised Blood Spots. | Biotech Hunter | Biotech Hunter